Immunocore (IMCR)

NASDAQ: IMCR · Real-Time Price · USD

30.15

0.05 (0.17%)

At close: May 01, 2025, 3:59 PM

30.12

-0.10%

Pre-market: May 02, 2025, 05:57 AM EDT

Immunocore Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-51.09M	-43.37M	-41.22M	-131.52M	-74.09M	-103.93M	-71.63M
Depreciation & Amortization	4.2M	4.09M	6.13M	7.01M	8.98M	9.21M	6.71M
Stock-Based Compensation	34.19M	32.47M	32.89M	48.89M	8.16M	3.06M	666K
Other Working Capital	50.2M	5.78M	19.2M	-11.66M	-28.27M	-11.92M	67.58M
Other Non-Cash Items	-6.38M	3.97M	-7.42M	-14.89M	38.45M	22.64M	-3.4M
Deferred Income Tax	n/a	n/a	-2.92M	-9.4M	-13.27M	-22.26M	-16.55M
Change in Working Capital	45.13M	5.78M	-12.88M	-16.81M	-28.8M	-10.09M	67.58M
Operating Cash Flow	26.06M	2.94M	-31.27M	-129.75M	-60.57M	-101.38M	-16.63M
Capital Expenditures	-5.17M	-5.42M	-2.2M	-1.01M	-3.07M	-4.28M	-3.54M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-350M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	27.45M
Other Investing Acitivies	44K	-1.17M	2.43M	513K	3.54M	139K	34.1M
Investing Cash Flow	-355.13M	-5.42M	233K	-495K	467K	-4.14M	58.01M
Debt Repayment	352.5M	n/a	n/a	n/a	45.13M	-4.04M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-8.62M	34.35M	-1.29M	-10.63M	-145.23K	-711K	101K
Financial Cash Flow	343.88M	34.35M	138.23M	276.25M	115.94M	55.13M	101K
Net Cash Flow	13.11M	40.15M	114.31M	146.03M	55.75M	-50.42M	41.5M
Free Cash Flow	20.89M	-2.48M	-33.47M	-130.76M	-63.65M	-105.65M	-20.16M